Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT02858856
Eligibility Criteria:
Inclusion Criteria:
* men and women aged over 18 years
* patients who have histologically or cytologically confirmed breast tumor
* patients who applicable AC(doxorubicin + cyclophosphamide)
* ECOG score 0 to 2
Exclusion Criteria:
* patient impossible to orally intake
* patient with dementia, delirium and depression
* patient suffering from diseases like chronic hepatitis B, C or hepatocirrhosis
* severe liver disability (3-fold the normal high range value for ALT, AST)
* patient who has diabetes not controlled by diet, hypertension, hyperthyroidism,
* severe systemic disease
* use of other investigational products within the past 30 days
* hypersensitivity to investigational product
* others who are judged not to be appropriate to study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02858856
Study Brief:
Protocol Section:
NCT02858856